Peanut allergy reduction in high-risk pediatric patients

被引：4

作者：

Hopper, Jaime ^{[1
]}

Hopp, Courtney ^{[1
]}

Durbin, Jessica ^{[2
]}

机构：

[1] Indiana Univ, Hlth Methodist Hosp, Indianapolis, IN 46204 USA

[2] Indiana State Univ, Terre Haute, IN 47809 USA

来源：

NURSE PRACTITIONER | 2018年 / 43卷 / 03期

关键词：

allergy; food allergies; immunotherapy; oral immunotherapy; peanut allergy; pediatric; prevention;

D O I：

10.1097/01.NPR.0000530210.24654.36

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

The prevalence of food allergies has doubled in the past 10 years. Peanut allergies are a significant public health issue and are the primary reason for food-related anaphylactic reactions that result in death. Evidence supports that early introduction of the peanut protein (or in combination with immunotherapy) to the highly allergic may safely desensitize patients, which could lead to less adverse allergic reactions and alter allergy management overall.

引用

页码：35 / 39

页数：5

共 50 条

[11] The development of allergy in high-risk children [J].

Burr, ML ;

Merrett, TG ;

Dunstan, FDJ ;

Maguire, MJ .

CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (11) :1247-1253

[12] Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma [J].

Mora, Jaume .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (05) :647-653

[13] Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy [J].

Chinthrajah, R. Sharon ;

Sindher, Sayantani B. ;

Nadeau, Kari C. ;

Leflein, Jeffrey G. ;

Spergel, Jonathan M. ;

Petroni, Daniel H. ;

Jones, Stacie M. ;

Casale, Thomas B. ;

Wang, Julie ;

Carr, Warner W. ;

Shreffler, Wayne G. ;

Wood, Robert A. ;

Wambre, Erik ;

Liu, Jinzhong ;

Akinlade, Bolanle ;

Atanasio, Amanda ;

Orengo, Jamie M. ;

Hamilton, Jennifer D. ;

Kamal, Mohamed A. ;

Hooper, Andrea T. ;

Patel, Kiran ;

Laws, Elizabeth ;

Mannent, Leda P. ;

Adelman, Daniel C. ;

Ratnayake, Anoshie ;

Radin, Allen R. .

ALLERGY, 2024, :827-842

[14] Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study [J].

Du Toit, George ;

Roberts, Graham ;

Sayre, Peter H. ;

Plaut, Marshall ;

Bahnson, Henry T. ;

Mitchell, Herman ;

Radulovic, Suzana ;

Chan, Susan ;

Fox, Adam ;

Turcanu, Victor ;

Lack, Gideon .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) :135-U215

[15] Pediatric Patients with Asthma: A High-Risk Population for Subsequent Hospitalization [J].

Shaw, Michele R. ;

Daratha, Kenn B. ;

Odom-Maryon, Tamara ;

Bindler, Ruth C. .

JOURNAL OF ASTHMA, 2013, 50 (06) :548-554

[16] Ondansetron dose response curve in high-risk pediatric patients [J].

Lawhorn, CD ;

Kymer, PJ ;

Stewart, FC ;

Stoner, JM ;

Shirey, R ;

Volpe, P .

JOURNAL OF CLINICAL ANESTHESIA, 1997, 9 (08) :637-642

[17] The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma [J].

Greenwood, Katie L. ;

Foster, Jennifer H. .

EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) :1257-1262

[18] Investigation of gut microbiota in pediatric patients with peanut allergy in outpatient settings [J].

Li, Shouming ;

Huang, Jingyi ;

Xie, Yunyun ;

Wang, Di ;

Tan, Xin ;

Wang, Yufan .

FRONTIERS IN PEDIATRICS, 2025, 13

[19] Current state and advances in desensitization for peanut allergy in pediatric age [J].

Foti Randazzese, Simone ;

Panasiti, Ilenia ;

Caminiti, Lucia ;

Catamero, Francesco ;

Landi, Massimo ;

De Filippo, Maria ;

Votto, Martina ;

Olcese, Roberta ;

Favuzza, Filippo ;

Giovannini, Mattia ;

Barberi, Salvatore .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (04)

[20] Maternal peanut consumption and risk of peanut allergy in childhood [J].

Abrams, Elissa M. ;

Sicherer, Scott H. .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (27) :E814-E815

← 1 2 3 4 5 →